Illumina announced that Robert Epstein has joined its board of directors. Epstein formerly was chief R&D officer and president of Medco-UBC, and he was Medco’s chief medical officer for 13 years. He retired from the company earlier this year when Express Scripts acquired Medco.
He also served as president of the International Society of Pharmacoeconomics and Outcomes Research, and he was on the board of directors of the Drug Information Association and the International Society of Quality of Life.
Erin O'Shea has been elected VP and chief scientific officer of the Howard Hughes Medical Institute. She will begin her duties part-time at the start of 2013 and will transition into them full-time in July.
For the past seven years, O'Shea has been director of the Harvard Faculty of Arts and Sciences Center for Systems Biology, and she is a professor of molecular and cellular biology, chemistry, and chemical biology at Harvard. Before she joined Harvard, O'Shea was an HHMI investigator at the University of California, San Francisco.